Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025
Shoulder Innovations (NYSE:SI), a commercial-stage medical technology company focused on the shoulder surgical care market, has scheduled two important events for September 9, 2025. The company will release its Q2 2025 financial results before the market opens. Additionally, management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference at 8:30 a.m. ET.
Investors can access the live and archived fireside chat through the company's investor relations website.
Shoulder Innovations (NYSE:SI), società medtech in fase commerciale focalizzata sul mercato della chirurgia della spalla, ha programmato due appuntamenti importanti per il 9 settembre 2025. La società pubblicherà i risultati finanziari del Q2 2025 prima dell'apertura del mercato. Inoltre, il management parteciperà a un colloquio informale (fireside chat) alla Morgan Stanley 23rd Annual Global Healthcare Conference alle 8:30 ET.
Gli investitori potranno seguire la fireside chat in diretta e in archivio sul sito web delle relazioni con gli investitori della società.
Shoulder Innovations (NYSE:SI), una compañía médica en fase comercial centrada en el mercado de cirugía de hombro, ha programado dos eventos importantes para el 9 de septiembre de 2025. La empresa publicará sus resultados financieros del 2T 2025 antes de la apertura del mercado. Además, la dirección participará en una conversación informal (fireside chat) en la Morgan Stanley 23rd Annual Global Healthcare Conference a las 8:30 a.m. ET.
Los inversores podrán acceder a la fireside chat en directo y a la grabación a través del sitio web de relaciones con inversores de la compañía.
Shoulder Innovations (NYSE:SI)는 어깨 수술 치료 시장에 주력하는 상업 단계의 의료기술 회사로서 2025년 9월 9일에 두 가지 주요 일정을 예정하고 있습니다. 회사는 시장 개장 전에 2025년 2분기 실적을 발표합니다. 또한 경영진은 Morgan Stanley 제23회 연례 글로벌 헬스케어 컨퍼런스에서 오전 8시 30분(ET)에 파이어사이드 챗(fireside chat, 비공식 대화)에 참여합니다.
투자자들은 회사의 투자자 관계 웹사이트를 통해 라이브 및 아카이브된 파이어사이드 챗에 접속할 수 있습니다.
Shoulder Innovations (NYSE:SI), une société de technologie médicale en phase commerciale axée sur le marché de la chirurgie de l'épaule, a programmé deux événements importants pour le 9 septembre 2025. La société publiera ses résultats financiers du T2 2025 avant l'ouverture des marchés. De plus, la direction participera à un fireside chat lors de la Morgan Stanley 23rd Annual Global Healthcare Conference à 8h30 ET.
Les investisseurs pourront suivre le fireside chat en direct et en replay via le site web des relations investisseurs de la société.
Shoulder Innovations (NYSE:SI), ein medizintechnisches Unternehmen in der kommerziellen Phase mit Schwerpunkt auf dem Schulteroperationsmarkt, hat für den 9. September 2025 zwei wichtige Termine angekündigt. Das Unternehmen wird die Finanzergebnisse für Q2 2025 vor Handelsbeginn veröffentlichen. Darüber hinaus wird das Management um 8:30 Uhr ET an einem Fireside Chat auf der Morgan Stanley 23rd Annual Global Healthcare Conference teilnehmen.
Investoren können den Fireside Chat live sowie als Aufzeichnung über die Investor-Relations-Website des Unternehmens abrufen.
- None.
- None.
Company to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on the Same Day
On the same day, members of management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The fireside chat will take place at 8:30 a.m. ET / 5:30 a.m. PT on September 9, 2025.
A live and archived version of the fireside chat will be available on the "Investor Relations" section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.
About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.
Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-second-quarter-2025-financial-results-on-september-9-2025-302541489.html
SOURCE Shoulder Innovations
FAQ
When will Shoulder Innovations (NYSE:SI) release Q2 2025 earnings?
What time is Shoulder Innovations' presentation at the Morgan Stanley Healthcare Conference?
How can investors access Shoulder Innovations' Morgan Stanley conference presentation?
What is Shoulder Innovations' main business focus?
